THE METABOLISM OF l-SERYLGLYCINE O(35S)-SULPHATE IN THE RAT

Authors:
  • NTN Tudball
    N Tudball
  • YNY Noda
    Y Noda
  • KDKs Dodgson
    Ks Dodgson

Abstract
The preparation of potassium L-serylglycine O-sulphate and the corresponding S35-labelled ester is described. Intraperitoneal injection of potassium L-serylglycine O[S35] -sulphate to rats results in about 75% of the radioactivity of the dose appearing in the urine within 48 hr. Almost 72% of the radioactivity recovered in the urine was in the form of inorganic [ S35] sulphate. Analysis of urines by paper chromatography showed the presence of unchanged L-seryglycine O[S35]-sulphate and several other unidentified S35-labeUed materials. It was established that micro-organisms of the gastrointestinal tract do not play any significant role in the production of inorganic [S35] sulphate from the injected ester. L-Serylglycine O-sulphate was hydrolysed by crude dipeptidase preparations from rat kidney and intestine to yield L-serine O-sulphate and glycine as the sole products.

This publication has 11 references indexed in Scilit: